REPONEX PHARMACEUTICALS A/S

CVR 30082346 · Public limited company (A/S) · Active · Medium risk

REPONEX PHARMACEUTICALS A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 19 annual reports have been published, of which 2 more than six months after the end of the financial year.

Bankruptcy risk for REPONEX PHARMACEUTICALS A/S

2.3%
probability of bankruptcy within 12 months
Medium risk

1.6 × the average (1.41%) · higher risk than 84% of active Danish companies

Lowest riskHighest risk

Increases the risk

Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
30082346
Status
Active
Company type
Public limited company (A/S)
Founded
(19 years)
Address
Slotsmarken 12, 1. th
2970 Hørsholm
Municipality
Hørsholm
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 850k
Employees
1 (2018)
Auditor
BDO Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late3 of 19
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)1
CEO changes in total9
CEO's previous bankruptcies0
Other companies at the address58
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Revenue–DKK 0DKK 0
Net profit–DKK -11.9mDKK -14.1m
Equity–DKK -8.8mDKK 3.2m
Total assets–DKK 3.6mDKK 8.1m
Cash–DKK 445k–

Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · BDO Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025169
1 Jan 2024 – 31 Dec 2024107
1 Jan 2023 – 31 Dec 2023109
1 Jan 2022 – 31 Dec 2022121
1 Jan 2021 – 31 Dec 2021117
1 Jan 2020 – 31 Dec 2020183
1 Jan 2019 – 31 Dec 2019171
1 Jan 2018 – 31 Dec 2018169
1 Jan 2017 – 31 Dec 2017134
1 Jan 2016 – 31 Dec 2016151
1 Jan 2015 – 31 Dec 2015173
1 Jan 2014 – 31 Dec 2014202 Late
1 Jan 2013 – 31 Dec 2013191 Late
1 Jan 2012 – 31 Dec 2012159
1 Jan 2011 – 31 Dec 2011178
1 Jan 2010 – 31 Dec 2010132
1 Jan 2009 – 31 Dec 2009152
1 Jan 2008 – 31 Dec 2008153
4 Dec 2006 – 31 Dec 2007163

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMikael Thiesen
CEOJon Steffen Therkildsen
CEOMichael Secher
CEOTorsten Bjørn
CEOThomas Kaas Selsø
BoardCharlotte PahlCurrent
BoardTroels Peter TroelsenCurrent
BoardChristian Vinding ThomsenCurrent
BoardTroels Peter Troelsen
BoardJacob Rosenberg
BoardHenrik Bulskov
BoardTroels Peter Troelsen
BoardErik Lennard Vitting Skovbjerg
BoardLisbeth Thyregod
BoardTroels Peter Troelsen
BoardSigbjørn Georg Nielsen Kjærgård
BoardKatrine Hoff Schlichtkrull
BoardChristian Vinding Thomsen
BoardSigbjørn Georg Nielsen Kjærgård
BoardPeter Mørch Eriksen
BoardMette Zacho
Owner (100%)Pharma Equity Group A/SCurrent
Owner (5%)BREGNERØDVEJ AUTO ApS
Owner (5%)CLINICURO ApS
Owner (25%)BIOPHARMA HOLDING ApS
Owner (33%)DANISH MEDICAL CONSULTS ApS
Owner (20%)DANISH MEDICAL CONSULTS ApS
Owner (5%)VULKAN INVEST ApS
Owner (15%)DANISH MEDICAL CONSULTS ApS
Owner (5%)FINANSMANAGEMENT ApS
Owner (10%)DANISH MEDICAL CONSULTS ApS
Owner (20%)BIOPHARMA HOLDING ApS
Owner (5%)Beier Holding ApS
Owner (5%)DANISH MEDICAL CONSULTS ApS
Owner (5%)NIELS ERIK JESPERSEN HOLDING ApS
Owner (10%)Beier Holding ApS
AuditorBDO Statsautoriseret RevisionspartnerselskabCurrent
AuditorREVISOR ERIK LUND-LARSEN
AuditorRevisionsFirmaet Edelbo og Lund-Larsen I/S
AuditorGRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorGrant Thornton, Godkendt Revisionspartnerselskab
AuditorBDO Holding VII, statsautoriseret revisionsaktieselskab
FounderPOLINVEST ApSCurrent

The CEOs' other companies

Mikael Thiesen – 25 other companies, of which 10 bankrupt

Jon Steffen Therkildsen – 5 other companies, of which 2 bankrupt

Michael Secher – 19 other companies, of which 6 bankrupt

Torsten Bjørn – 21 other companies, of which 2 bankrupt

Thomas Kaas Selsø – 28 other companies, of which 1 bankrupt

Address history (4 moves)

Slotsmarken 12, 1. th, 2970 Hørsholm
Slotsmarken 18, 2. th, 2970 Hørsholm
Slotsmarken 12, 1. th, 2970 Hørsholm
c/o POLINVEST A/S, Kongevejen 153, 2830 Virum
c/o POLINVEST A/S, Store Kongensgade 48, 5., 1264 København K

Former names

REPONEX PHARMACEUTICALS A/S – now
REPONEX PHARMACEUTICALS ApS –
TRIFOILIUM ApS –
WYSPA ApS –

Employees per year

Number of employees at REPONEX PHARMACEUTICALS A/S per year112017: 120172018: 12018

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about REPONEX PHARMACEUTICALS A/S

Has REPONEX PHARMACEUTICALS A/S gone bankrupt?

No, REPONEX PHARMACEUTICALS A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of REPONEX PHARMACEUTICALS A/S?

Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.

Who is the auditor of REPONEX PHARMACEUTICALS A/S?

REPONEX PHARMACEUTICALS A/S most recently used BDO Statsautoriseret Revisionspartnerselskab.

When was REPONEX PHARMACEUTICALS A/S founded?

REPONEX PHARMACEUTICALS A/S was founded on 4 December 2006.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.